HCQ for COVID-19
1st treatment shown to reduce risk in
March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.
No treatment is 100% effective.
Protocols combine treatments.
Preliminary results of Senegal trial with 181 patients showing faster recovery with HCQ, and even faster recovery with HCQ+AZ.
Seydi et al., 2 May 2020, preprint, 1 author.
